INVO Bioscience Inc. (INVO)
NASDAQ: INVO
· Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM
INVO Bioscience Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 549.18M | 840.41M | 741.4M | 471.59K | 942.93K | 475.13K | 232.42K | 1.06M | 112.48K | 2.19M | 90.14K | 285.7K | 1.96M | 3.84M | 5.68M | 4.71M | 6.64M | 8.42M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | -2.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 645.94M | 710.86M | 740.76M | 2.94M | 3.02M | 3.04M | 3.09M | 1.08M | 1.13M | 1.17M | 1.24M | 1.28M | 1.35M | 1.49M | 1.49M | 237.48K | 141.27K | 280.16K |
Other Long-Term Assets | 9.43B | 2.22B | 2.28B | n/a | n/a | 5.54M | 7.91M | 6.94M | -5.8M | -3.34M | -3.48M | 3.15M | 3.27M | 3.47M | 3.53M | 200.58K | 881.83K | 280.16K |
Receivables | 242.25M | 173.61M | 174.88M | 257.05K | 257.21K | 176.89K | 140.55K | 116.78K | 74.91K | 99.72K | 77.15K | 71.31K | 56.48K | 58.72K | 50.47K | 50.66K | 47.87K | 527.65K |
Inventory | 212.61M | 216.46M | 219.76M | 241.54K | 250.07K | 266.45K | 264.51K | 254.22K | 280.02K | 270.92K | 263.6K | 280.13K | 282K | 294.63K | 287.77K | 290.39K | 250.78K | 268.35K |
Other Current Assets | 395.31M | 338.64M | 182.29M | 987.3K | 945.85K | 806.48K | 622.29K | 365.23K | 374.71K | 250.88K | 190.2K | 305.15K | 247.68K | 228.18K | 282.75K | 275.82K | 289.84K | 363.97K |
Total Current Assets | 1.4B | 1.57B | 1.32B | 1.96M | 2.4M | 1.72M | 1.26M | 1.79M | 842.13K | 2.81M | 621.09K | 942.29K | 2.55M | 4.42M | 6.31M | 5.33M | 7.23M | 9.58M |
Property-Plant & Equipment | 428.75M | 451.25M | 466.68M | 2.76M | 3.06M | 3.78M | 6.57M | 6.63M | 4.66M | 2.17M | 2.24M | 2.32M | 2.4M | 2.47M | 2.54M | 2.25M | 1.55M | 203.32K |
Goodwill & Intangibles | 7.41B | 26.79B | 41.64B | 9.36M | 9.56M | 9.77M | 9.97M | 9.97M | n/a | n/a | n/a | 132.68K | 132.71K | 132.55K | 132.09K | 132.15K | 129.44K | 123.49K |
Total Long-Term Assets | 17.92B | 30.17B | 45.13B | 15.06M | 15.64M | 16.59M | 19.63M | 17.68M | 5.8M | 3.34M | 3.48M | 3.74M | 3.88M | 4.1M | 4.16M | 2.82M | 2.7M | 606.97K |
Total Assets | 19.32B | 31.74B | 46.45B | 17.02M | 18.03M | 18.32M | 20.89M | 19.48M | 6.64M | 6.15M | 4.1M | 4.68M | 6.42M | 8.52M | 10.47M | 8.15M | 9.93M | 10.19M |
Account Payables | n/a | n/a | n/a | n/a | 2.38M | 2.8M | 2.33M | 1.85M | n/a | 1.85M | 1.35M | 689.56K | 466.98K | 462.21K | 443.42K | 515.58K | 306.25K | 446.85K |
Deferred Revenue | 834.85M | 725.33M | 602.36M | 562.4K | 416.75K | 513.42K | 408.77K | 229.92K | 161.19K | 46.75K | 119.88K | 98.66K | 77.36K | 5.79K | 5.9K | 714.29K | 714.29K | 714.29K |
Short-Term Debt | 4.03B | 5.63B | 7.46B | 1.72M | 1.46M | 1.68M | 1.51M | 1.7M | 1.03M | 1.1M | 994.25K | 229.17K | 226.75K | 224.36K | 221.99K | 448.05K | 346.86K | 366.14K |
Other Current Liabilities | 7.6B | 12.37B | 9.87B | 6.15M | 2.85M | 2.85M | 3.57M | 123.43K | n/a | n/a | 119.88K | 98.66K | 77.36K | 5.79K | 359.7K | 354.4K | 252.74K | 309.53K |
Total Current Liabilities | 12.46B | 18.72B | 17.93B | 8.66M | 7.99M | 8.96M | 8.22M | 4.88M | 4.47M | 4.45M | 3.41M | 1.66M | 1.28M | 1.08M | 1.25M | 2.14M | 1.72M | 1.86M |
Long-Term Debt | 3.1B | 3.21B | 3.32B | 1.13M | 1.17M | 1.21M | 1.25M | 1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.13B | 2.5B | 5B | 5M | 5M | 5M | 5M | 7.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 4.22B | 5.71B | 8.32B | 8.39M | 8.68M | 9.35M | 11.78M | 14.22M | 3.88M | 1.61M | 1.67M | 1.73M | 1.79M | 1.85M | 1.9M | 3.65M | 3.86M | 2.73M |
Total Liabilities | 16.69B | 24.43B | 26.24B | 17.04M | 16.67M | 18.31M | 19.99M | 19.1M | 8.34M | 6.06M | 5.08M | 3.39M | 3.07M | 2.93M | 3.16M | 5.79M | 5.57M | 4.59M |
Total Debt | 7.13B | 8.84B | 10.78B | 5.34M | 5.38M | 6.38M | 8.68M | 8.81M | 5.13M | 2.95M | 2.66M | 1.96M | 2.01M | 2.07M | 2.12M | 1.78M | 1.7M | 418.93K |
Common Stock | 83K | 74K | 37K | 391.00 | 386.00 | 262.00 | 249.00 | 247.00 | 83.00 | 1.4K | 1.22K | 1.22K | 1.21K | 1.21K | 1.19K | 1.05K | 1.05K | 1.04K |
Retained Earnings | -90.2B | -84.87B | -67.16B | -63.54M | -61.91M | -59.41M | -57.82M | -55.82M | -54.57M | -52.33M | -49.78M | -47.02M | -44.47M | -41.67M | -38.89M | -38.75M | -36.51M | -34.69M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -500K | -6M | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a |
Shareholders Equity | 2.63B | 3.34B | 12.75B | -23.32K | 1.36M | 10.15K | 892.83K | 372.8K | -1.71M | 88.47K | -977.61K | 1.29M | 3.36M | 5.59M | 7.31M | 2.59M | 4.36M | 5.6M |
Total Investments | n/a | n/a | n/a | 2.94M | 3.02M | 3.04M | 916.25K | 1.08M | 1.13M | 1.17M | 1.24M | 1.28M | 1.35M | 1.49M | 1.49M | 237.48K | 141.27K | 280.16K |